SUDO-550, an oral therapy for MS, was found to be safe and to reach the brain in its first human clinical trial, trial ...

A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

This granted U.S. patent represents an important milestone for JayaBio,” said Pawel Krysiak, President and Chief Executive Officer of Jaya Biosciences. “It underscores our commitment to addressing the ...

A Northwestern team transformed a common chemotherapy drug into a powerful, targeted cancer therapy using spherical nucleic ...

Detailed price information for Amicus Therapeutics (FOLD-Q) from The Globe and Mail including charting and trades.

A new laser treatment has a potential to treat age-related macular disease (yellow deposits in the macula of an eye), aiming ...

Watchmaker Genomics today announced the launch of TAPS+, a next-generation technology that unites genetic and epigenetic ...

Hansa Biopharma AB ( (SE:HNSA) ) has issued an announcement. Hansa Biopharma announced that its CEO, Renée Aguiar-Lucander, and CFO, Evan Ballantyne, will attend the 2025 Truist Securities Biopharma ...

A specific genetic detector could offer potential to doctors in reversing damages in the sensory cells of the inner ear, ...

The mandatory Phase 1 clinical trial in healthy volunteers in China precedes the inclusion of Chinese clinical sites by late 2026 into the single Global Phase 3 registration trial of BV100 in ...

DOHA: Sidra Medicine, a member of Qatar Foundation, has announced the launch of Qatar’s first Autologous Serum Eye Drops, a ...